The hypothalamo-pituitary-adrenal axis in major affective disorder: A review

Nordic Journal of Psychiatry

Volumn 55, Issue 5, 2001, Pages 359-363

  Christensen, Maj Vinberg ^a   Kessing, Lars Vedel ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Affective disorder; Cortisol; Depressive disorder; Dexamethasone suppression test; Stress

Indexed keywords

AFFECTIVE NEUROSIS; ARTICLE; BRAIN DYSFUNCTION; BRAIN SCINTISCANNING; DIAGNOSTIC IMAGING; FOLLOW UP; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL PATIENT; METHODOLOGY; NEUROENDOCRINE SYSTEM; PROSPECTIVE STUDY; REVIEW; SAMPLE;

DEXAMETHASONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 0035161795     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/080394801317080873     Document Type: Article

References (49)

1. Neuroendocrine mechanisms and the precipitation of depression by life events
2. General review, steroids and depression
3. Pharmacoendocrinology of major depression
4. The dexamethasone suppression test for diagnosis and prognosis in psychiatry commentary and review
5. Stress hormones: Their interaction and regulation
6. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
7. Glucocorticoids and the genesis of depressive illness: A psychobiological model
8. The "glucocorticoid cascade hypothesis" in man
9. A specific laboratory test for the diagnosis of melancholia
10. Hypothalamo-pituitary-adrenal axis abnormalities in depression: A review and a model
11. The dexamethasone suppression test for melancholia
12. The dexamethasone suppression test: Fact and artefact
13. The DST as a predictor of outcome in depression: A meta-analysis
14. The dexamethasone suppression test: An overview of its current status in psychiatry
15. Correlation between the dexamethasone suppression test in depressed patients and clinical response
16. DST abnormality as a predictor of course in major depression
17. Multiplicity of depressive episodes: Phenomenological and neuroendocrine correlates
18. The dexamethasone suppression test in patients with mood disorders
19. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania
20. Plasma dexamethasone concentration and cortisol response during manic episodes
21. DST studies in psychotic depression. A meta-analysis
22. Characterisation of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotrophin and beta-endorphin
23. Psychiatric implications of basic and clinical studies with corticotrophin-releasing factor
24. Neuroendocrine effects of intravenous ovine corticotrophin-releasing factor in affective disorder patients and normal controls
25. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
26. Prediction of depressive relapse in bipolar patients using corticotrophin-releasing hormone challenge test
27. The dexamethasone/corticotrophin-releasing hormone test in depression in bipolar and unipolar affective illness
28. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression
29. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression
30. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression
31. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
32. The role of corticotropin releasing factor in the pathophysiology of psychiatric disorders
33. The rationale for corticotropin-releasing hormone receptor (CHR-R) antagonist to treat depression and anxiety
34. Adrenal gland enlargement in major depression
35. Adrenal gland volume in major depression: Relationship to basal and stimulated pituitary-adrenal cortical axis function
36. Adrenal gland volume in major depression
37. Pituitary size in depression
38. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: Relationship to dexamethasone suppression test results in patients
39. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
40. Stress and glucocorticoids in ageing
41. Hippocampal atrophy in recurrent major depression
42. Hippocampal volume reduction in major depression
43. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders
44. The relationship of endogenous cortisol to psychiatric disorder: A review
45. The effect of diagnosis and age on the DST: A metaanalytic approach
46. Age and the dexamethasone suppression test: Results from a broad unselected patient population
47. The oCRH stimulation test before and after clinical recovery from depression
48. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: Review of recent research strategies in depression